Articles for GlaxoSmithKline (LSE: GSK)

Why GlaxoSmithKline’s share price could be about to skyrocket

A 5%+ yield, double-digit profit growth, improving balance sheet and dirt-cheap valuation put GlaxoSmithKline plc (LON: GSK) in a fantastic position. More »

GlaxoSmithKline’s share price is rising. Is it time to buy?

GlaxoSmithKline plc's (LON: GSK) share price has bounced 10% in the last few weeks. Is now the time to take a closer look at... More »

Why I believe the GlaxoSmithKline share price is now too cheap to ignore

I believe the GlaxoSmithKline plc (LON: GSK) share price can only go up from here. More »

GlaxoSmithKline plc isn’t the only pharma stock I’d buy today

Royston Wild explains why GlaxoSmithKline plc (LON: GSK) isn't the only pharma star that could make you a fortune. More »

Top shares for April

We asked our analysts to share their top stock picks for the month. More »

Why I’d buy 6% yielder GlaxoSmithKline plc for my ISA after this news

A new deal has lifted the GlaxoSmithKline plc (LON:GSK) share price. Roland Head explains why he'd rate the stock as a buy. More »

GlaxoSmithKline plc isn’t the only pharma stock worth investing in for retirement

This company could generate high returns alongside GlaxoSmithKline plc (LON:GSK) (GSK.L). More »

Is Footsie dividend stalwart GlaxoSmithKline plc’s dividend under threat?

Here's why recent positive numbers from pharma giant GlaxoSmithKline plc (LON:GSK) may not be enough to prevent it from cutting its prized dividend. More »

Why I’d buy and hold dividend stocks GlaxoSmithKline plc & Taylor Wimpey plc

GlaxoSmithKline plc (LON: GSK) and Taylor Wimpey plc (LON: TW) could be among the best dividend payers of the next decade. More »

Are GlaxoSmithKline plc shares a bargain after FY2017 results?

GlaxoSmithKline plc (LON: GSK) currently yields 6.1% and trades on a P/E of 11.8. Does that make the shares a 'buy'? More »

Why I’d avoid this 4.5% dividend yielder and buy GlaxoSmithKline plc instead

This 4.5% dividend yielder may look attractive, but here’s why my money would go on GlaxoSmithKline plc (LON: GSK) More »

One 5% yielder I’d consider over GlaxoSmithKline plc

Are you considering alternative dividend picks amid an earnings plateau at GlaxoSmithKline plc (LON:GSK)? More »

GlaxoSmithKline plc isn’t the only Footsie dividend stock I’d buy today

Royston Wild explains why GlaxoSmithKline (LON: GSK) isn't the only income star that could make you a fortune. More »

GlaxoSmithKline plc isn’t the only unloved dividend stock I’d buy and hold forever

Roland Head explains why now could be the time to start buying GlaxoSmithKline plc (LON:GSK). More »

Why I believe you can double your money with Footsie champion GlaxoSmithKline plc

GlaxoSmithKline plc (LON: GSK) could help you double your money in 2018. More »

2 stocks I’d own during a 2018 market correction

Nervous investors may find these high-income, non-cyclical businesses great places to park their cash in 2018. More »

Why GlaxoSmithKline plc shares could be the buy of the decade

After a challenging few years, the fortunes of GlaxoSmithKline plc (LON:GSK) could be set for a dramatic improvement. More »

Should I swap GlaxoSmithKline plc for this turnaround stock?

Could this company offer higher returns than GlaxoSmithKline plc (LON:GSK)? More »

Why I would buy out-of-favour Bunzl plc over GlaxoSmithKline plc

Harvey Jones reckons Bunzl plc (LON: BNZL) could fly back into favour before fellow struggler GlaxoSmithKline plc (LON: GSK). More »

Which is the better dividend stock: Royal Dutch Shell plc or GlaxoSmithKline plc?

Royal Dutch Shell plc (LON: RDSB) and GlaxoSmithKline plc (LON: GSK) are two of the most popular dividend stocks, but does one have stronger... More »